Ferrero Paola, Said Matilde, Sánchez Gina, Vittone Leticia, Valverde Carlos, Donoso Paulina, Mattiazzi Alicia, Mundiña-Weilenmann Cecilia
Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 60 y 120, 1900 La Plata, Argentina.
J Mol Cell Cardiol. 2007 Sep;43(3):281-91. doi: 10.1016/j.yjmcc.2007.05.022. Epub 2007 Jun 6.
We aimed to define the relative contribution of both PKA and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) cascades to the phosphorylation of RyR2 and the activity of the channel during beta-adrenergic receptor (betaAR) stimulation. Rat hearts were perfused with increasing concentrations of the beta-agonist isoproterenol in the absence and the presence of CaMKII inhibition. CaMKII was inhibited either by preventing the Ca(2+) influx to the cell by low Ca plus nifedipine or by the specific inhibitor KN-93. We immunodetected RyR2 phosphorylated at Ser2809 (PKA and putative CaMKII site) and at Ser2815 (CaMKII site) and measured [(3)H]-ryanodine binding and fast Ca(2+) release kinetics in sarcoplasmic reticulum (SR) vesicles. SR vesicles were isolated in conditions that preserved the phosphorylation levels achieved in the intact heart and were actively and equally loaded with Ca(2+). Our results demonstrated that Ser2809 and Ser2815 of RyR2 were dose-dependently phosphorylated under betaAR stimulation by PKA and CaMKII, respectively. The isoproterenol-induced increase in the phosphorylation of Ser2815 site was prevented by the PKA inhibitor H-89 and mimicked by forskolin. CaMKII-dependent phosphorylation of RyR2 (but not PKA-dependent phosphorylation) was responsible for the beta-induced increase in the channel activity as indicated by the enhancement of the [(3)H]-ryanodine binding and the velocity of fast SR Ca(2+) release. The present results show for the first time a dose-dependent increase in the phosphorylation of Ser2815 of RyR2 through the PKA-dependent activation of CaMKII and a predominant role of CaMKII-dependent phosphorylation of RyR2, over that of PKA-dependent phosphorylation, on SR-Ca(2+) release during betaAR stimulation.
我们旨在确定蛋白激酶A(PKA)和钙/钙调蛋白依赖性蛋白激酶II(CaMKII)级联反应在β-肾上腺素能受体(βAR)刺激过程中对兰尼碱受体2(RyR2)磷酸化及通道活性的相对贡献。在存在和不存在CaMKII抑制的情况下,用浓度递增的β-激动剂异丙肾上腺素灌注大鼠心脏。通过低细胞外钙(Ca)加硝苯地平阻止Ca(2+)流入细胞或使用特异性抑制剂KN-93抑制CaMKII。我们通过免疫检测在Ser2809(PKA和假定的CaMKII位点)和Ser2815(CaMKII位点)磷酸化的RyR2,并测量了肌浆网(SR)囊泡中[³H]-兰尼碱结合和快速Ca(2+)释放动力学。在能够保留完整心脏中所达到的磷酸化水平的条件下分离SR囊泡,并使其主动且均匀地加载Ca(2+)。我们的结果表明,在βAR刺激下,RyR2的Ser2809和Ser2815分别被PKA和CaMKII剂量依赖性地磷酸化。PKA抑制剂H-89可阻止异丙肾上腺素诱导的Ser2815位点磷酸化增加,而福斯可林可模拟该作用。如[³H]-兰尼碱结合增强和快速SR Ca(2+)释放速度加快所示,CaMKII依赖性的RyR2磷酸化(而非PKA依赖性的磷酸化)导致了β诱导的通道活性增加。目前的结果首次表明,通过PKA依赖性激活CaMKII,RyR2的Ser2815磷酸化呈剂量依赖性增加,并且在βAR刺激期间,CaMKII依赖性的RyR2磷酸化在SR-Ca(2+)释放方面比PKA依赖性的磷酸化起主要作用。